TP53 and cancer: With the exception of p53 mutations, which occur in 70–80% of oesophagogastric adenocarcinomas (OGA) of the CIN subtype, mutations in cancer driver genes are relatively rare in these cancers, and SCNAs are considered the predominant type of genetic driver alterations [3,4].